GlassScriptPhysician profile
Finda L Guyton
NPI 1255322582
$5,637.48
in general payments reported to CMS, 2019-2025
9 companies · $1,648 in 2025
The $1,648 reported for 2025 was more than what 93% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $31.38 · 2021: $124 · 2024: $3,835 · 2025: $1,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,400 · Food and Beverage: $82.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,400.00 |
| Food and Beverage | $82.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $5,415.51 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $90.24 | 2021 | |
| Daiichi Sankyo INC. | $34.17 | 2020-2021 | |
| Coopersurgical, INC. | $19.39 | 2024 | Paragard T 380a |
| Hologic Sales and Service, LLC | $18.53 | 2025 | Myosure Tissue Removal Device |
| Baxter Healthcare | $15.53 | 2024 | Perclot |
| Amgen INC. | $15.34 | 2020 | |
| Evofem Biosciences, INC. | $15.21 | 2021 | |
| Organon LLC | $13.56 | 2025 | Jada System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Finda Guyton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.